ArticleFrontiers in pediatrics2025
Case Report: A 14-year-old boy with recurrent pancreatitis and autism-response to steroid and rituximab therapy.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the case of a 14-year-old boy with a history of recurrent pancreatitis, autism, and learning disabilities who presented with non-bilious vomiting, epigastric pain, and a progressively enlarging abdominal mass. He was diagnosed with IgG4-related autoimmune pancreatitis. Initial corticosteroid therapy achieved only temporary remission, with disease relapse occurring after 4 months. Rituximab was subsequently introduced, resulting in sustained disease control by depleting B lymphocytes and reducing disease flares, consistent with previous reports. The patient has remained clinically stable for 1 year. This case highlights the clinical presentation, diagnostic challenges, and therapeutic considerations of this rare condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.